Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Based on the Application of Peripheral Blood Polygene Methylation Markers in Postoperative Recurrence Monitoring of Colorectal Cancer

NCT05444491 is registered in ClinicalTrials.gov with Singlera Genomics Inc. as lead sponsor.

NCT NCT05444491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05444491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Based on the Application of Peripheral Blood Polygene Methylation Markers in Postoperative Recurrence Monitoring of Colorectal Cancer
Lead sponsor
Singlera Genomics Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
June 20, 2022
Completion date
June 30, 2026
Enrollment
800 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer